Adam Laponis - 28 Oct 2025 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Financial Officer
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Adam Laponis
Issuer symbol
TWST
Transactions as of
28 Oct 2025
Net transactions value
$0
Form type
4
Filing time
30 Oct 2025, 16:05:09 UTC
Previous filing
10 Oct 2025
Next filing
03 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Laponis Adam Chief Financial Officer C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD, SOUTH SAN FRANCISCO /s/ Kendra Fox, as Attorney-in-Fact for Adam Laponis 30 Oct 2025 0001827198

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +25,000 +27% $0.000000 116,525 28 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement.